New spermicide: FHI developing propranolol.
D000569:Americas; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D003906:Developing Countries; D004467:Economics; D005193:Family Planning Services; D009656:North America; D010342:Patient Acceptance of Health Care; D004364:Pharmaceutical Preparations; D012106:Research; D012725:Sexual Behavior; D013089:Spermatocidal Agents; D013672:Technology; D013812:Therapeutics; D014481:United States; D014622:Vaginal Creams, Foams, and Jellies
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004364:Pharmaceutical Preparations; D013089:Spermatocidal Agents; D014622:Vaginal Creams, Foams, and Jellies
Americas; Contraception--pharmacodynamics; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Contraceptive Methods--pharmacodynamics; Contraceptive Usage; Developed Countries; Developing Countries; Drugs; Economic Factors; Family Planning; Method Acceptability; North America; Northern America; Reproductive Behavior; Research And Development; Spermicidal Contraceptive Agents--pharmacodynamics; Technology; Treatment; United States; Vaginal Spermicides--pharmacodynamics; Vaginal Tablet--pharmacodynamics